Clinical TrialsSearch results
Number of results: 229
Other
- Cluster randomised controlled trial of hip protectors for the prevention of hip fractures among women in nursing homes
- Osteoporosis with risk factors for falls and hip fractures
- Department of Orthopaedic Surgery, Osaka City University Medical School
- 2006-08-15
Other
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05: A Multi-Center Phase II Study in Children with Newly Diagnosed Acute Myeloid Leukemia
- Acute Myeloid Leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2006-11-01
Other
- A randomized phase III trial of AP(Doxorubicin+Cisplatin) versus DP(Docetaxel+Cisplatin), TC(Paclitaxel+Carboplatin) as adjuvant chemotherrapy in patients with high risk group of endometrial carcinoma
- patients with high risk group of endometrial carcinoma which is removed surgically
- Japanese Gynecologic Oncology Group
- 2006-11-15
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11
Other
- Assessment of Beta-Blocker Treatment in Japanese Patients with Chronic Heart Failure
- Chronic heart failure
- J-CHF Study Group
- 2006-12-13
Other
- Follow-up study for localized prostate cancer treated by hormonal therapy or radical prostatectomy.
- Prostate cancer
- J-CaP study group
- 2006-12-30
Other
- MIRACLE-ICD outcome measured in Japanese indication
- Congestive Heart Failure, Ventricular Tachyarrhythmia.
- Medtronic Japan, Co., Ltd.
- 2007-02-01
Other
- Okayama Screening Study for Anderson-Fabry Disease in Maintenance Dialysis
- Fabry disease
- Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
- 2007-02-28
Other
- Clinical examination about immunoadsorption therapy for dilated cardiomyopathy
- dilated cardiomyopathy
- Department of Cardiology, Kitasato Institute Hospital
- 2007-03-01
Other
- A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II/III study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-03-16